Thanks for sharing Baa Baa. Good article and food for thought.
https://www.marketscreener.com/quote...22/financials/
Average broker forecast for FY22 is 25 cps on sales recovering to $1,387m and EBITDA margin of 20%.
At $7.68 that puts them on a FY22 forward PE of 31...more or less the same when Geoff Babbidge was running it many years ago and it was growing really strongly.
My thoughts are that Covid variants will dog us for many many years and the CCP will get increasingly forthright in pushing buy Chinese made. Are these risks factored into the current share price with that forward PE ?
I think there's a lot of people jumping on board this as a momentum trade. With no forecast dividend from an investment point of view taking into account the risks I am dubious that the above analysts average forecast supports a share price materially higher than the current one. If I'm wrong I'm okay with that and good luck to shareholders.